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Preterm delivery (PTD), deﬁned as birth before 37 completed weeks of gestation, is the leading cause of perinatal morbidity and
mortality. Evaluation of the cervical morphology and biometry with transvaginal ultrasonography at 16–24 weeks of gestation is
a useful tool to predict the risk of preterm birth in low- and high-risk singleton pregnancies. For instance, a sonographic cervical
length (CL) > 30mm and present cervical gland area have a 96-97% negative predictive value for preterm delivery at <37 weeks.
Available evidence supports the use of progesterone to women with cervical length ≤25mm, irrespective of other risk factors. In
womenwithpriorspontaneousPTD withasymptomaticcervical shortening(CL ≤25mm),prophylactic cerclage procedure must
be performed and weekly to every two weeks follow-up is essential. This article reviews the evidence in support of the clinical
introduction of transvaginal sonography for both the prediction and management of spontaneous preterm labour.
1.Introduction
Preterm delivery occurs in 5–13% of pregnancies before 37
weeks’ gestation. Preterm delivery is a major cause of perina-
tal morbidity and mortality [1–7]. Most of the damage and
death cases occur in infants delivered before 34 weeks. The
incidence of early preterm delivery (<34 gestational weeks’)
is 1–3.6% [1, 2]. Preterm delivery is associated with a high
prevalence of severe neurological deﬁcits and developmental
disabilities and is a leading cause of infant and neonatal
mortality. Preterm neonates are at increased risk of devel-
oping respiratory distress syndrome, bronchopulmonary
dysplasia, sepsis, intraventricular hemorrhage, patent ductus
arteriosus, necrotizing enterocolitis, and disorders related to
gestational age at birth [8, 9].
Risk factors for preterm delivery include demographic
characteristics, behavioral factors, and aspects of obstetric
history such as previous preterm birth. Demographic factors
for preterm labor include black race, extremes of mater-
nal age (<18 or >35), low socioeconomic status, and low
prepregnancy weight. Preterm labor and birth can be asso-
ciated with stressful life situations (e.g., domestic violence,
closefamily death,work andhomeenvironment)eitherindi-
rectly by associated risk behaviors or directly by mechanisms
not completely understood. Many risk factors may manifest
in the same gravida [1–3, 10].
The exact mechanism of preterm labor is largely un-
known but is believed to include decidual hemorrhage (e.g.,
abruption, mechanical factors such as uterine overdistension
from multiplegestationorpolyhydramnios), cervicalincom-
petence (e.g., cone biopsy), m¨ ullerian duct abnormalities,
ﬁbroid uterus, cervical inﬂammation (e.g., resulting from
bacterial vaginosis, trichomonas), maternal inﬂammation
and fever (e.g., urinary tract infection), hormonal changes
(e.g., mediated by maternal or fetal stress), and uteropla-
cental insuﬃciency (e.g., hypertension, insulin-dependent
diabetes, drug abuse, smoking, alcohol consumption). Each
of these underlying causes can initiate the cascade of events
that ultimately lead to uterine activity and cervical dilation.
Thus, a reduction in the spontaneous PTD rate may require2 Journal of Pregnancy
notonlyaccurateidentiﬁcationofpatientsatriskforpreterm
delivery but also eﬀective treatment strategies aimed at cor-
recting the underlying causes of preterm labor [1–3, 10–16].
Methods used for predicting preterm birth include risk
scoringsystem,assessments ofsalivary estriol,fetalﬁbronect-
in (FFN), maternal serum alpha fetoprotein (MS-AFP),
cervicovaginal intracellular adhesion molecule-1 (ICAM-
1), phosphorylated insulin-like growth factor binding pro-
tein-1 (phIGFBP-1), cervicovaginal beta-human chorionic
gonadotropin (β-hCG), and the cervical morphology and
biometry. While hospital tocodynamometry has been eﬀec-
tive for monitoring uterine contractions to evaluate preterm
labor, home uterine activity monitoring (HUAM) has not
been proven valuable in detecting or preventing preterm
birth and is not currently recommended for use [17, 18].
2.Biomarkersof PretermBirth
The most commonly used and most predictive method for
preterm birth is fetal ﬁbronectin. Fetal ﬁbronectin (fFN) is a
glycoprotein produced by fetal membranes and trophoblasts
which form a biological glue that adheres the fetal mem-
branes and placenta to the decidua. Before approximately 20
gestational weeks it is normally found (4%) in secretions of
the cervix and vagina. Thereafter it is a pathological ﬁnding
and a marker of choriodecidual disruption [19–21]. Initially,
Lockwood et al. reported that the presence of cervicovaginal
fetal ﬁbronectin in the second and third trimesters of
pregnancy identiﬁes a subgroup of women who are at high
risk for preterm delivery. They showed that fFN had a
sensitivity of 81.7% and speciﬁcity of 82.5% for detecting
PTD at 37 weeks of gestation in asymptomatic patients [19].
The systematic review by Honest et al. demonstrated that in
asymptomatic women the best summary likelihood ratio for
positive fFN results was 4.01 (95% conﬁdence interval 2.93
to 5.49) for predicting birth before 34 weeks’ gestation, with
corresponding summary likelihood ratio for negative fFN
results of 0.78 (0.72 to 0.84). Among symptomatic women
the best summary likelihood ratio for positive results for fFN
was 5.42 (4.36 to 6.74) for predicting birth within 7–10 days
of testing, with corresponding ratio for negative fFN results
of 0.25 (0.20 to 0.31) [22].
R e c e n t l y ,c e r v i c a lo rv a g i n a lf e t a lﬁ b r o n e c t i ni st h em o s t
powerful biochemical prediction marker of SPTD due to
the high negative predictive values [23, 24]. Deplange et al.
investigated a sequential test with fetal ﬁbronectin detection
after ultrasound measurement of cervical length to predict
preterm delivery in women with preterm labor. They
reported that the sensitivity, speciﬁcity, and positive and
negative predictive values of fetal ﬁbronectin positiveness
were 75, 71, 17, and 97% for delivery within 14 days; those
of cervical length inferior or equal to 20mm were 75, 52, 21,
and 92% for delivery before 34 weeks. The eﬃciency of the
sequential test was similar with excellent negative predictive
value: sensitivity, speciﬁcity, and positive and negative
predictive values of 75, 63, 26, and 93.5% for prediction
of preterm delivery before 34 entire weeks. The use of this
sequential test could have avoided 37% of ﬁbronectin tests
[25].
The maternal salivary E3 level seems to correlate well
with the serum level and it has been shown that elevated
maternal serum E3 levels are associated with increased risk
of preterm birth in asymptomatic and symptomatic women
presenting for symptoms of preterm labor [26]. It also has
lowsensitivityandiscurrentlymainlyusedinclinicalsettings
due to its negative predictive value (i.e., women who test
negative are at very low risk of preterm birth and no inter-
ventions are necessary) [17, 27]. This test is thus currently
more useful for research than for clinical practice [27].
Previous research has showed an association with ele-
vated AFPand adverse pregnancy outcomes,includingspon-
taneous preterm birth. The premature delivery screening can
be used at the beginning of the 2nd trimester. Cut-oﬀ value
of 1.8MoM for marking the higher-risk group was used for
marking the high-risk group. Women with equal or higher
values of AFP were 3.8 times more likely to have premature
delivery than those with lower AFP values(95% CI: 2.2; 6.3).
Sensitivity of 25% and speciﬁcity of 92% were proven [28].
At a patient-level meta-analysis of 24 studies by Yuan et al.,
there was no association with preterm birth (OR = 1.80,
95% CI: 0.92–2.68) at women in whom AFP was elevated in
isolation. Their ﬁndings suggest that maternal AFP levels are
strongly related to preterm birth, but only in the context of
other abnormal pregnancy markers [29].
Marvin et al. reported that measurement of sICAM-1 in
cervicovaginal ﬂuid has potential as a predictor of preterm
deliveryinwomen withsymptoms ofpretermlabor.Elevated
sICAM-1concentrationspredictedshort intervalstodelivery
(area under receiver operator characteristic (ROC) curves,
0.70–0.72 for delivery within 3, 7, and 10 days), with
high speciﬁcity. Characteristics for delivery within 3 days
at a 3ng/mL threshold for a positive test were sensitivity
of 33.3%, speciﬁcity of 98.9%, and positive and negative
predictivevaluesof75.0%and93.9%,respectively.Predictive
ability was independent of and complementary to that of
fetal ﬁbronectin [30]. Kwon et al. showed that ICAM-1 gene
K469E polymorphism may be a candidate region and useful
predictor of susceptibility to PTD [31].
The recent studies showed that a new cervicovaginal
test to detect phosphorylated insulin-like growth factor
binding protein-1 (phIGFBP-1) may improve the accuracy
of predicting preterm delivery. The phIGFBP-1 is mainly
secreted by maternal decidual cells and may be an indicator
of tissue damage of the choriodecidual interface. In the ﬁrst
trimester, 24.5%ofwomen, andinthemid-second trimester,
20.2% of women, had an elevated cervical ﬂuid phIGFBP-1
level [32, 33]. Rahkonen et al. investigated an assessment of
phIGFBP-1inpredictingpretermdeliveryin5180unselected
pregnant women. They found that the rates of spontaneous
PTD before 32 and before 37 weeks of gestation were higher
in women with an elevated cervical ﬂuid phIGFBP-1 level,
compared with women who had cervical phIGFBP-1 of <10
micrograms/L (1.1% versus 0.3% and 5.7% versus 3.2%,
resp.). An elevated phIGFBP-1 level in the ﬁrst trimester
was an independent predictor for PTD before 32 and before
37 weeks of gestation, with odds ratios of 3.0 (95% CI
1.3–7.0) and 1.6 (95% CI 1.2–2.3), respectively. Cervical
phIGFBP-1 levels of 10 micrograms/L or more in the ﬁrstJournal of Pregnancy 3
trimester predicted PTD before 32 and before 37 weeks of
gestation, with sensitivities of53.8% and 37.0%, respectively.
The negative predictive values were 99.7% and 96.8%. They
showed that elevated cervical ﬂuid phIGFBP-1 levels in the
ﬁrst trimester were associated with an increased risk of
spontaneous PTD [34].
In another study, Rahkonen et al. investigated that short
cervix (<25mm), positive phIGFBP-1 test, combination of
both, and clinician’s judgment were all associated with
preterm delivery < or = 3 4w e e k so rw i t h i n1 4d a y si nat o t a l
of 246 women between 22 and 34 weeks of gestation. The
negative predictive values for delivery < or = 34 weeks were
97.4, 97.6, 97.1, and 98.7%, respectively, and within 14 days
98.7, 99.0, 98.3, and 99.6%, respectively. The corresponding
positive LRs for delivery < or = 34 weeks were 6.8, 3.8, 75.0,
and 14.9, and within 14 days 9.7, 5.5, 107.3, and 17.1. The
negative LRs were 0.6, 0.6, 0.7, and 0.3 and 0.5, 0.3, 0.6, and
0.2. They showed that the rapid phIGFBP-1-test has a high
negative predictive value for preterm delivery, comparable to
that of ultrasonographic cervical length measurement [35].
Paternoster et al. assessed phIGFBP-1 in cervical secretions
and the sonographic measurement of cervical length in
210 symptomatic patients. They found that 26mm was the
best cut-oﬀ value for cervical length in terms of predicting
preterm delivery (LR+, 3.69; LR−, 0.22), with a sensitivity of
86.4%, speciﬁcity of 71.9%, positive predictive value (PPV)
of 34.5%, and negative predicting value (NPV) of 96.8%.
They also found that the sensitivity, speciﬁcity, PPV, and
NPVof phIGFBP-1 ofa positive phIGFBP-1 test were 52.9%,
89.2%, 48.7%, and 90.8%, respectively, in predicting birth
before 37 weeks’ gestation with an OR of 9.3 (95% CI, 4.05–
21.3), an LR+ of 4.9, and an LR− of 0.5 and that their
combination had an NPV of 90%, greater speciﬁcity, and a
better PPV (64.3%) than either method alone for preterm
delivery [36]. Bittar et al. found that measuring cervical
length at 22–24weeks’ gestation and phIGFBP-1 at 30 weeks’
gestation improved the prediction of preterm delivery over
either method used alone [37].
Audibert et al. reported that IGFBP-1 screening did not
predict preterm delivery and fFN screening provided the
best predictive capacity. A policy of contingent use of testing
for fFN after CL measurement or contingent use of CL
measurement after fFN screening (depending on available
resources) is a promising approach to limit use of resources
[38]. Cooley et al. studied the relationship between levels
of insulin-like growth factors 1 and 2 (IGF-1, IGF-2) and
insulin-like growth factor binding protein 3 (IGFBP-3) in
antenatal maternal serum and gestational age at delivery.
They reported that there was no signiﬁcant association
between maternal IGF-1 or IGF-2 and preterm birth (PTB).
Maternal mean IGFBP-3 levels are signiﬁcantly reduced in
cases complicated by delivery <32 completed weeks [39].
Cervicovaginal beta-hCG measurement in patients with
preterm labor may be used as a predictive test. Bagga et al.
studied with a group of 100 women with a singleton preg-
nancy with preterm labour between 26–36 weeks’ gestation.
Cervicovaginal secretions were collected for HCG assay and
cervical length was measured by transvaginal sonography
(TVS). These parameters were analysed to predict preterm
birth. The preterm delivery rate was 55%; 24% delivered
within 48h and 11% within 7 days of admission. The sen-
sitivity, speciﬁcity, positive predictive value (PPV), and
negative predictive values (NPV) of cervical length less than
or equal to 2.5cm to predict delivery within 48h and 7 days
of admission were 62.5%, 89.5%, 65.2%, and 88.3% and
60.0%, 96.9%, 91.3%, and 81.8%, respectively; and those of
qualitative HCG were 87.5%, 80.3%, 58.3%, and 95.3% and
77.1%, 86.2%, 75%, and 87.5%, respectively. HCG value of
> or = 45mIU/mL was the optimal cut-oﬀ,with a sensitivity,
speciﬁcity, PPV, and NPV for predicting delivery within 48h
and 7 days to be 95.8%, 73.7%, 53.5%, and 98.2% and
85.7%, 80%, 69.8%, and 91.2%, respectively. Combining
either qualitative or quantitative HCG assay with cervical
length signiﬁcantly increased the sensitivity and NPV of
cervical length alone for prediction of preterm delivery both
within 48h and 7 days. It was concluded that increased
cervicovaginal HCG and reduced cervical length predicted
an increased risk of preterm delivery in women with preterm
labour. Qualitative cervicovaginal HCG assay may be used
as a bedside test to predict preterm delivery within 48h or
within 7 days [40].
Adhikari et al. investigated prediction of the risk of pret-
erm birth (<37 weeks) or early preterm birth (<34 weeks) by
cervicovaginal HCG and cervical length measured between
24 and 28 weeks of gestation in asymptomatic women at
high risk for preterm birth. They reported that to predict
delivery<37weeks,cervicallength<2.95cmhadasensitivity,
speciﬁcity, positive predictive value (PPV), and negative
predictive value (NPV) of 75%, 80.1%, 71.4%, and 90.7%
respectively, and cervicovaginal HCG > 4.75mIU/mL had
a sensitivity, speciﬁcity, PPV, and NPV of 70%, 61.81%,
40%, and 85%, respectively. To predict delivery <34 weeks,
cervical length <2.65cm had a sensitivity, speciﬁcity, PPV,
and NPVof50%, 85.50%,23.08%,and 95.16%,respectively;
and cervicovaginal HCG > 14mIU/mL had a sensitivity,
speciﬁcity, PPV, and NPV of 83.3%, 85.5%, 33.3%, and
98.3%, respectively. Cervical length was superior to predict
delivery <37 weeks, whereas HCG was superior to predict
delivery <34 weeks. Their combination was superior to
predict preterm birth both <37 weeks or <34 weeks, than
either parameter used alone [41].
Combined marker evaluationcould be used as a sensitive
parameter for identifying women at risk of spontaneous
preterm delivery but it is not possible to obtain biomarkers
in most of the clinics. Therefore, the evaluation of the cervix
with utrasoundography is important.
3.CervicalAssessment by Ultrasonography
Cervix can be evaluated by transabdominal, translabial, and
transvaginal ultrasound (TVU). Each technique has its costs
and beneﬁts; however, a review of the current literature will
show that the transvaginal method of cervical assessment
is the most reliable. TVU is objective, reproducible, and
acceptable to patients. At the transabdominal approach, the
cervix may not be visualised in up to 50% of cases unless
the bladder is full, but bladder ﬁlling signiﬁcantly increases
the length of the cervix. The transperineal route is limited by4 Journal of Pregnancy
both the inconsistency in correlation between transvaginal
and transperineal measurements and the inadequate visual-
isation of the cervix in up to 25% of cases. Cervical changes
such as dilatation of the internal cervical os with funneling
(beaking) of the membranes can be easily appreciated
by TVU, but not by digital examination [42–44]. The
ultrasound images were analyzed to assess changes in the
cervix that are associated with spontaneous prematurity and
to evaluate ultrasonography as an indicator of the risk of
preterm delivery [45].
Before the evaluation of the cervix with transvaginal
ultrasonography,ﬁrstofall,thepatientshouldhaveanempty
bladder and be placed in dorsal lithotomy position. A dis-
tended bladder can alter the shape of the cervix and compass
the cervical canal in some cases preventing the detection of
cervical incompetence [44, 46]. The vaginal probe should
be placed in the anterior fornix without pressure. If the
probe is pressed too hard against the cervix, it can obscure
cervical incompetence. Initial orientation is established by
locating the sagittal view of the cervix. The cervical canal
should appear asa hypoechoic groove.The junction between
amniotic membrane and cervical canal is designated as the
internal os. The external os is located at the lower end of
the cervix. Cervical length (CL) is deﬁned as the distance
between the internal to external os along the endocervical
canal (Figure 1). If the cervical canal is curved, the CL can
be measured either as the sum of two straight lines that
essentially follow the curve or by a straight line between
internal and external os. A short CL is usually straight, and
the presence of curved cervix generally signiﬁes a CL greater
than 25mm and, therefore, is a reassuring ﬁnding [47, 48].
If the cervical canal is closed, CL is probably the only
parameter that needs to be measured. If a normal appearing
internaloscannotbevisualized,thecervixshouldbeassessed
further to determine whether funneling (the internal os
widthisgreaterthan5mm)ispresent(Figure 2).Iffunneling
is present, the shape can be recorded [49, 50]. A continuous
processoffunnelinghasbeendescribed,goingfromanormal
T shape to Y, then V, and ﬁnally a U shape. It appears that
U shape is more likely to be associated with PTD, compared
with a V-shaped funnel [51, 52].
CL during pregnancy can range from 25 to 70mm and
ultrasound width of thecervicalcanal ranges from 2 to4mm
[47, 48, 53, 54]. Percentile values for CL between 17 and
32 weeks of gestation are indicated in Table 1 (unpublished
data). Before 14 weeks, it is diﬃcult to distinguish the lower
uterine segment from the endocervical canal. Therefore, the
measurement of the true cervical length is very diﬃcult
before 14 weeks. There is agreement that the best time to
examine patients with this method to estimate their preterm
birth risk is between 18 and 24 gestational weeks. Several
studies reported that the measurement of cervical length
in the ﬁrst trimester is not predictive of preterm delivery
[55, 56]. Finally, Greco et al. have recently reported that the
endocervical length at 11 to 13 weeks is shorter in pregnan-
cies resulting in spontaneous delivery before 34 weeks than
in those delivering after 34 weeks [57].
Many parameters other than CL and presence or absence
of a funnel have been studied including funnel width, funnel
Figure 1: Transvaginal ultrasound image of the uterine cervix.
Figure 2: Transvaginal ultrasound image of the cervical funneling.
Table 1: Percentile values for CL between 17 and 32 weeks of
gestation.
Group (GW) Percentiles
5 1 02 55 07 59 09 5
17–20 GW 33,00 34,00 37,00 38,50 41,00 44,00 45,00
21–24 GW 29,00 30,00 34,50 37,00 39,00 41,00 43,00
25–28 GW 27,00 28,00 33,00 35,00 37,00 40,00 41,40
29–32 GW 26,50 28,00 31,00 33,00 36,50 39,00 40,00
length, endocervical canal dilation, cervical index (funnel
length +1/functional length), anterior and posterior cervical
width, cervical angle, cervical canal contour, and cervical
gland area (CGA) [58–60].
4.The CervicalMorphologyand Biometryfor
the PredictionofPretermBirth
The length of the cervix may be useful in predicting the
risk of premature delivery, with a shorter cervix predicting a
higherrisk. Ashort CLisabetterpredictorofearly PTDthan
later PTD [47, 61–63]. In a prospective multicenter study,
Iams et al. performed TVS of the cervix in low-risk womenJournal of Pregnancy 5
Table 2: Studies of CL measured by transvaginalultrasonography to predict preterm birth in low-riskwomen.
Authors n GW at testing Outcome (GW) Cutoﬀ value (mm) Sen. (%) Spec. (%) PPD (%) NPD (%)
Tongsong et al. [6] 730 28–30 <37 <35 65.9 62.4 19.4 92.8
2915 24 <35 ≤30 54.0 76.3 9.3 97.4
Iams et al. [47] 24 <35 ≤25 37.3 92.2 17.8 97.0
2531 28 <35 ≤30 69.9 68.5 7.0 98.5
28 <35 ≤25 49.4 86.8 11.3 98.0
Fukami et al. [58] 3030 16–19 22–31 ≤30 50.0 98.5 8.3 99.9
32–36 ≤30 18.2 98.9 33.3 97.6
Pires et al. [59] 338 21–24 <37 <20 18.0 98.1 40.0 94.8
<35 <20 27.3 97.9 30.0 97.6
Barber et al. [7] 2351 18–22 <37 <30 39.0 92.0 31.0 94.0
with a singleton pregnancy at 24 weeks (n = 2915) and 28
weeks (n = 2531) of gestation. At 24 weeks, a cervical length
of ≤25mm had a sensitivity of 37%, a speciﬁcity of 92%,
a positive predictive value 18%, and a negative predictive
value %97 in predicting spontaneous preterm birth at <35
weeks’ gestation. The RR of preterm birth before 35 weeks
of gestation was about sixfold higher (95% CI: 3.84–9.97)
among women whose cervical length was less than 25mm
than that among women with a cervical length above 40mm
[47].
To et al. conducted a population-based prospective mul-
ticentre study in 39284 women with singleton pregnancies
attending for routine hospital antenatal care in London,
UK. The detection rate of spontaneous delivery before 32
weeksbymeasuring cervicallengthwas55%,with 10%false-
positive rate [64]. Hibbard et al. measured the CL by TVS
at 16–22 weeks in 760 singleton pregnancies in unselected
women attending routine antenatal care. Relative risks (95%
CI) for spontaneous preterm delivery before 37 weeks were
3.8 (2.6, 5.6), 5.4 (3.3, 9.0), and 6.3 (3.0, 13.0) for the
tenth (30mm), ﬁfth (27mm), and two and a half (22mm)
percentiles, respectively; RRs for before 35 weeks were 4.5
(2.9, 6.9), 7.5 (4.5, 12.5), and 7.8 (3.6, 16.7). Sensitivity
ranged from 13 to 44%, speciﬁcity 90–99%, positive predic-
tive value 15–47%, and negative predictive value 80–98% for
prediction of preterm birth before 35 weeks [65].
A study of cervical length in low-risk women found an
eightfold(95%CI3–19)increasedriskofpretermbirthwhen
the cervix was less than30mm at 18 to22 weeks of gestation,
butthe sensitivity and positive predictive values were low: 19
and 6 percent, respectively [61].Althoughlowsensitivity and
low positive predictive value limit its usefulness, it has high
negative predictive values and it can be used in screening of
low-risk obstetric populations (Table 2).
A number of studies have assessed the predictive value
of TVS CL in women with some of the most important of
these risk factors including a prior PTD [50, 66, 67], a
history ofexcisional cervical procedures (conebiopsy, LEEP)
[68, 69], mullerian anomaly [70], andtwo ormore voluntary
termination [70]( Table 3). In a prospective study of 705
high-risk women, the risk of spontaneous PTB before 35
weeks decreased by approximately 6% for each additional
millimeter of CL (OR: 0.94, 95% CI: 0.92–0.95) and by
approximately 5% for each additional week of pregnancy
during which the CL was measured (OR:0.95,95% CI: 0.92–
0.98). They conclude that gestational age at which transvagi-
nal ultrasound cervical length is measured signiﬁcantly
aﬀects the calculation of risk of spontaneous preterm birth.
The spontaneouspretermbirth risk increases as thelength of
the cervix declines and as the gestational age decreases [71].
Funnelingcomprising40–50%ofthetotalcervicallength
or a persistently shortened cervix (<25–30mm) has, in
several studies, been associated with an increased risk of
preterm birth [17, 47, 49, 65]. To et al. measured cervical
length among 6334 women with singleton pregnancies at
22–24 weeks and looked for the presence of funneling to
evaluateits possible additional risk. Funneling of theinternal
oswaspresentinabout4%ofpregnanciesandtheprevalence
decreased withincreasing cervicallengthfrom98%whenthe
length was ≤15mm to about 25% for lengths of 16–30mm
and less than 1% at lengths of >30mm. The rate of preterm
delivery was 6.9% in those with funneling compared to 0.7%
in those without funneling. However, logistic regression
analysis demonstrated that funneling did not provide a
signiﬁcant additional contribution to cervical length in the
prediction of spontaneous delivery before 33 weeks (OR, for
short cervix = 24.9 P<0.0001; OR, for funneling = 1.8,
P = 0.40) [50].
As an independent ﬁnding, funneling does not add ap-
preciably to the risk of early gestational age at delivery asso-
ciated with a shortened cervical length. So, women with a
longcervixand funneling are not at increased risk of preterm
delivery [50, 51, 72].
In the past few years publications have also highlighted
the importance of another morphological ultrasonographic
marker for PTD, named as the cervical gland area (CGA).
The CGA is deﬁned as the sonographically hipoechoic or
hiperechoic zone surrounding the endocervical canal. If the
CGA around the endocervical canal is not detected, it is
deﬁned as absent [58, 59].
Fukami et al. reported that the absence of CGA at second
trimester ultrasonography appeared to be new and powerful
predictor of PTD before 32 weeks gestation [58], similar to
that reported by Pires et al. [59]( Table 4). Asakura et al.
reported that short CL (<20mm) with absent CGA rep-
resents an independent predictor for PTD. The absence of6 Journal of Pregnancy
Table 3: Studies of CL in high-risk women with spontaneous PTD.
Authors n GW at testing Outcome (GW) Cutoﬀ value (mm) Sen. (%) Spec. (%) PPD (%) NPD (%) RR
Berghella et al. [43] 96 14–30 <35 25.0 59.0 85.0 45.0 91.0 4.8
Owen et al. [48] 183 16–24 <35 25.0 69.0 80.0 55.0 88.0 3.4
Crane and Hutchens [66] 193 24–30 <35 30.0 63.6 77.2 28.0 93.8 —
Adhikari et al. [41] 79 24–28 <37 29.5 75.0 80.1 71.4 90.7 —
<34 26.5 50.0 85.5 23.1 95.2 —
Berghella et al. [68] 45 16–24 <35 25.0 60.0 69.0 35.0 86.0 2.5
Crane et al. [69] 75 24–30 <37 30.0 70.0 90.8 53.8 95.2 —
Airoldi et al. [70] 64 14–23+6 <35 25.0 71.0 91.0 50.0 95.0 13.5
Visintine et al. [72] 131 14–24 <35 25.0 53.0 75.0 48.0 78.0 2.2
Table 4
Authors n GW at testing Test Outcome (GW) Sen. (%) Spec. (%) PPD (%) NPD (%)
Fukami et al. [58] 3030 16–19
Absence CGA 22–31 75.0 99.8 54.5 99.9
CL ≤ 30mm + Absence CGA 22–31 50.0 99.8 40.0 99.9
Absence CGA 32–36 2.3 99.7 18.2 97.2
CL ≤ 30mm + Absence CGA 32–36 2.3 99.7 20.0 97.2
Pires et al. [59] 338 21–24 Absence CGA <35 54.5 99.1 66.7 98.5
Absence CGA <37 38.1 9.7 88.9 96.0
the CGA as a new marker for the risk of PTD has to be con-
ﬁrmed by further investigations [73].
5.ManagementOptionsforShortCervix
Many interventions have been proposed in an attempt to
prevent PTD in women at high risk.
Bed rest and hydration are often recommended in an
attempttopreventPTDinwomenathighrisk,butthereisno
consistent evidence that they are able to delay delivery [74].
Progesterone’s role in the treatment and prevention of
preterm birth is still uncertain. A Cochrane meta-analysis
from 2005showed that intramuscular progesterone isassoci-
atedwith areductioninrisk ofpretermbirthbefore37gesta-
tionalweeks[75].Fonsecaet al.inamulticenter,randomized
trial proposed using daily vaginal micronized progesterone
(200mg) to women with CL 15mm or less, irrespective of
other risk factors. They showed a signiﬁcant reduction in
preterm birth at <34 weeks with intravaginal progesterone
in patients treated based on premature cervical shortening
as the indication for therapy [76]. O’Brien et al. analyzed
547 randomized patients with a history of preterm birth.
They found that the progesterone-treated patients had
signiﬁcantly less cervical shortening than the placebo group.
As i g n i ﬁ c a n td i ﬀerence was also observed between groups
for categorical outcomes including the frequency of cervical
length progression to ≤25mm and a ≥50% reduction in
cervical length from baseline in this subpopulation [67].
Further research is necessary and several randomized trials
a r eu n d e r w a yt oc l a r i f yt h ee ﬃcacy and fetal safety of proges-
terone treat.
Cervical cerclage is an old, easily performed procedure
for treatment of true cervical incompetence [77]. Dijkstra
etal.studied80womenwhoseprimaryphysiciandetermined
that a prophylactic (n = 50) or urgent cerclage (n = 30) was
indicated and had transvaginal ultrasonographic evaluation
before and after cerclage. They found that the mean ±
standard deviation precerclage cervical length was 27.2 ±
10.3 mm and after cerclage was 34.1 ± 9.9mm (n = 80,
P<0.001). The increase in cervical length after cerclage is
not predictive of term delivery [78]. Until recently, cerclage
was the only intervention studied to prevent PTB in asymp-
tomatic women with short CL. Rust et al. randomized 113
women with CL < 25mm or ≥25% funneling measured
between 16 and 24 weeks to either modiﬁed bed rest or
cerclage. No signiﬁcant diﬀerences between two groups re-
garding risk of PTB <34 weeks or perinatal death were
noted. It is important that women were included based on
an incidental ﬁnding of a short cervix without taking into
account other risk factors in the maternal history. Therefore,
the majority of women were considered low risk before the
sonographic ﬁndings [79]. To et al. also sampled 47,123
asymptomatic women and identiﬁed a cervix of 15mm or
less in 470, of whom 253 (54%) were randomized to either
cervical cerclage (n = 127) or expectant management (n =
126). No signiﬁcant diﬀerences in the rate of PTB <33
weeks or in perinatal or maternal morbidity or mortality
were noted. Again, women in this study were incidentally
found to have a short cervix. Subgroup analysis of the utility
of cerclage in the high-risk population, based on maternal
history, was not performed [80].
Cerclage is not indicated in low-risk patients. A case-
controlled study by Incerti et al. found that cerclage does not
reducePTBinlow-risk womenwith short CLcomparedwith
rest alone. However, this is not the case in women with pre-
vious PTD. However, this is not the case in women with
previousPTD[81].Arecentmulticenterrandomizedtrialin-
cluded 302 women with at least one prior PTB ≤32 weeksJournal of Pregnancy 7
and TVU CL < 25mm between 16 and 226/7 weeks random-
ized to either cerclage or no cerclage. PTB <35 weeks was
similar in both groups, butthe beneﬁt was most pronounced
when CL was <15mm, suggesting the presence of a more
signiﬁcant, and treatable, component of cervical insuﬃ-
ciency [82]. The systematic meta-analysis by Berghella et al.
has shown that Cerclage, when performed in women with
a singleton gestation, previous preterm birth, and cervical
length <25mm, seems to have a similar eﬀect regardless of
the degree of cervical shortening, including CL 16–24mm,
as well as CL ≤ 5.9mm [83].
Weeklyintramuscular17-alpha-hydroxyprogesteroneca-
proate (17 P) was compared with McDonald cerclage in
women with short CL ≤ 25mm at between 16 and 24 weeks’
gestation. The study was terminated, however, when the
interim analysis showed no diﬀerence in PTD <35 weeks
between treatment groups. However, cerclage may be more
eﬀective in preventing spontaneous PTD in women with CL
≤ 15mm [84]. In another study, Berghella et al. showed that
17 P had no additional beneﬁt for prevention of PTD in
women who had prior SPTD and got ultrasound-indicated
cerclageforCL<25mm. In womenwho didnot get cerclage,
17 P reduced previable birth and perinatal mortality [85].
Evaluation of the cervical morphology and biometry
with transvaginal ultrasonography at 16–24 weeks of ges-
tation is a useful tool to predict the risk of preterm birth
in low- and high-risk singleton pregnancies. For instance, a
sonographiccervicallength>30mmand presentCGAhavea
96-97% negative predictive value for preterm delivery at <37
weeks. Transvaginal evaluation of cervix during routine fetal
morphological examination helps identify asymptomatic
low-andhigh-risk womenforpredictionofpretermdelivery.
Available evidence supports the use of progesterone to
women with cervical length ≤25mm, irrespective of other
risk factors. In women with prior spontaneous PTD with
asymptomatic cervical shortening (CL ≤ 25mm) there
should be prophylactic cerclage procedure and weekly to
every two weeks follow-up.
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